Low skeletal muscle mass is predictive of dose-limiting toxicities in head and neck cancer patients undergoing low-dose weekly cisplatin chemoradiotherapy

BACKGROUND: The dose-limiting effect of CT-assessed low skeletal muscle mass (LSMM) measured at the level of the third cervical vertebra has been found in head and neck cancer patients receiving high-dose cisplatin chemoradiotherapy. The aim of this study was to investigate the predictive factors fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Becker, Jan-Niklas, Hermann, Robert, Wichmann, Jörn, Sonnhoff, Mathias, Christiansen, Hans, Bruns, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942991/
https://www.ncbi.nlm.nih.gov/pubmed/36802403
http://dx.doi.org/10.1371/journal.pone.0282015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942991/
https://www.ncbi.nlm.nih.gov/pubmed/36802403
http://dx.doi.org/10.1371/journal.pone.0282015

Ejemplares similares